1822230.ppt

20 de May de 2023
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1822230.ppt
1 de 31

Mais conteúdo relacionado

Similar a 1822230.ppt

Travail pre-terme: Orientation diagnostic et CATTravail pre-terme: Orientation diagnostic et CAT
Travail pre-terme: Orientation diagnostic et CATAxlerJEANPAUL
tt.dysfonction_erectile.ppttt.dysfonction_erectile.ppt
tt.dysfonction_erectile.pptmbusa2
APLIC ModulesAPLIC Modules
APLIC Modulesmyelinassociates
Le test de grossesseLe test de grossesse
Le test de grossesseS/Abdessemed
defis_frustrations.pptdefis_frustrations.ppt
defis_frustrations.pptmbusa2
APLICAPLIC
APLICmyelinassociates

Mais de OumBanat

FIV-ICSI-Procreatec.pdfFIV-ICSI-Procreatec.pdf
FIV-ICSI-Procreatec.pdfOumBanat
3213945 (1).ppt3213945 (1).ppt
3213945 (1).pptOumBanat
3302123 (1).ppt3302123 (1).ppt
3302123 (1).pptOumBanat
10265032.ppt10265032.ppt
10265032.pptOumBanat
9537138.ppt9537138.ppt
9537138.pptOumBanat
1736840.ppt1736840.ppt
1736840.pptOumBanat

1822230.ppt

Notas do Editor

  1. To achieve downregulation of endogenous gonadotropin secretion with a GnRH agonist a pretreatment period of 2 to 3 weeks is required. Furthermore, relatively high amounts of exogenous FSH are needed for adequate stimulation since during the whole period of stimulation endogenous FSH is deeply suppressed. Administration of the GnRH antagonist is only required during a short period of the stimulation, i.e. when a premature LH surge is likely to occur. GnRH antagonists do not induce initial stimulation of gonadotropin use. Furthermore a lower total dose of FSH is needed for stimulation, since with the use of a GnRH antagonist, FSH levels are only partly suppressed during the late follicular phase. Furthermore cessation of GnRH antagonist treatment ensures a rapid and predictable recovery of the pituitary gonadal axis, as in contrast to the GnRH agonists, since there is no desensitization or downregulation of the pituitary.